Celler

New cell therapy facility enters fight against chronic diseases

Retrieved on: 
Thursday, September 21, 2023
GMP, Heart, Tissue, Novo Nordisk Foundation Center for Protein Research, Human, Partnership, Technical University of Denmark, Education, Institute of technology, Biotechnology, University, Cancer, DKK, Research, Cell, Transplant, EUR, Student, Parkinson's disease, Hospital, Animal, Patient, Celler, Stem cell, Novo Nordisk Foundation, Conditional sentence, DTU, B cell, Kidney disease, Disease, Pharmaceutical industry, Fine chemical

The Novo Nordisk Foundation Cellerator will fill a critical gap in the Danish cell therapy ecosystem, helping to translate breakthroughs in cell therapy research into real-world treatments for people with diseases such as chronic heart failure, Parkinson's, kidney disease, type 1 diabetes and several forms of cancer.

Key Points: 
  • The Novo Nordisk Foundation Cellerator will fill a critical gap in the Danish cell therapy ecosystem, helping to translate breakthroughs in cell therapy research into real-world treatments for people with diseases such as chronic heart failure, Parkinson's, kidney disease, type 1 diabetes and several forms of cancer.
  • "We've seen major advances in the laboratory in recent years, but many promising cell therapy candidates face difficulties reaching clinical trials, partly because we can't currently develop cell therapy products in large, consistent quantities here in Denmark.
  • I'm thrilled to be heading an initiative that will change this and provide hope to people living with chronic diseases."
  • "The Cellerator will provide our researchers and students with a unique opportunity to translate cell technologies into cell therapy treatments.

New cell therapy facility enters fight against chronic diseases

Retrieved on: 
Thursday, September 21, 2023
GMP, Heart, Tissue, Novo Nordisk Foundation Center for Protein Research, Human, Partnership, Technical University of Denmark, Education, Institute of technology, Biotechnology, University, Cancer, DKK, Research, Cell, Transplant, EUR, Student, Parkinson's disease, Hospital, Animal, Patient, Celler, Stem cell, Novo Nordisk Foundation, Conditional sentence, DTU, B cell, Kidney disease, Disease, Pharmaceutical industry, Fine chemical

The Novo Nordisk Foundation Cellerator will fill a critical gap in the Danish cell therapy ecosystem, helping to translate breakthroughs in cell therapy research into real-world treatments for people with diseases such as chronic heart failure, Parkinson's, kidney disease, type 1 diabetes and several forms of cancer.

Key Points: 
  • The Novo Nordisk Foundation Cellerator will fill a critical gap in the Danish cell therapy ecosystem, helping to translate breakthroughs in cell therapy research into real-world treatments for people with diseases such as chronic heart failure, Parkinson's, kidney disease, type 1 diabetes and several forms of cancer.
  • "We've seen major advances in the laboratory in recent years, but many promising cell therapy candidates face difficulties reaching clinical trials, partly because we can't currently develop cell therapy products in large, consistent quantities here in Denmark.
  • I'm thrilled to be heading an initiative that will change this and provide hope to people living with chronic diseases."
  • "The Cellerator will provide our researchers and students with a unique opportunity to translate cell technologies into cell therapy treatments.

INAUGURAL WORLD PEACE CONCERT FUNDRAISER & VIP MASQUERADE GALA TO BENEFIT UKRANIAN REFUGEES TO BE HELD AT THE VERSACE MANSION IN MIAMI, JUNE 11TH

Retrieved on: 
Tuesday, May 17, 2022
Stellar, Aurora, Employment, City, Overalls, Housing, Food, Woman, Celler, Music, Survivor, Health, California Health Care Foundation, World peace, Clothing, Hope, The, Poly(methyl methacrylate), Safety, Technology, Refugee, Water, CEO, Marieme, Nightclub, Tourism

MIAMI, May 17, 2022 /PRNewswire/ -- Versailles Ventures, led by international attorney and global entrepreneur Bobbie Celler, will host their inaugural World Peace Concert Fundraiser and VIP Masquerade Gala at the iconic Versace Mansion in South Beach Miami, on Saturday, June 11th.  Proceeds from this first event will be used to purchase land and build homes for Ukrainian refugees, in addition to providing them the opportunity to gain employment in the location selected for their new communities.  Centered around the love of art, music, and fashion, combined with emerging technologies and innovation, the one-night event will be live-streamed globally, and host a multitude of onsite activations that will include an art auction specifically by Ukrainian artists, fashion show with a poolside Plexiglas catwalk, and live music performances. 85% of profits from the event will be donated to the Health Care Foundation in support of purchasing housing and building communities for the Ukrainian refugees. 

Key Points: 
  • Among the performers confirmed so far include, Greyson Chance, Gallant, Jules Aurora, Matt Steffanina, Jewels Gold, Meirlin, Nina Nesbitt, Shishi and Marieme.
  • In a heartfelt statement addressing the World Peace Concert Fundraiser charity event, Deputy-Prime-Minister of Ukraine Iryna Vereshchuk said: "So far, 374 people from Russian captivity may have returned to Ukraine.
  • A select amount of tickets for the World Peace Concert Fundraiser and VIP Masquerade Gala are available to the public now.
  • The inaugural event will be held at the Versace Mansion on June 11th in Miami Beach, FL.

BOBBIE CELLER AND EMERGENCY RECOVERY, INC. FILE LAWSUIT AGAINST GEICO FOR DEFAMATION

Retrieved on: 
Tuesday, March 1, 2022
Giant, Florida circuit courts, Bird, Torpedo, Circuit, GEICO, Goliath, Circuit court, Atmosphere, Westchester Interfaith/Interagency Network for Disaster and Emergency Recovery, Celler, Eleventh, ERI, Public relations, Insurance

MIAMI-DADE COUNTY,Fla., March 1, 2022 /PRNewswire/ --Bobbie Celler and his company Emergency Recovery, Inc. ("ERI") sued GEICO after it issued a press release stating that Celler and ERI engaged in fraudulent conduct.

Key Points: 
  • MIAMI-DADE COUNTY,Fla., March 1, 2022 /PRNewswire/ --Bobbie Celler and his company Emergency Recovery, Inc. ("ERI") sued GEICO after it issued a press release stating that Celler and ERI engaged in fraudulent conduct.
  • GEICO's press release was issued after it filed a lawsuit against Celler and ERI alleging they were engaged in a deceptive scheme against GEICO.
  • The lawsuit was dismissed twice by a judge as having no legal basis against Celler and ERI.
  • CELLER filed his case- Emergency Recovery, Inc. and Bobbie Celler v. Government Employees Insurance company, Geico Indemnity Company, Geico Casualty Company, and Geico General Insurance Company.

BOBBIE CELLER AND EMERGENCY RECOVERY, INC. FILE LAWSUIT AGAINST GEICO FOR DEFAMATION

Retrieved on: 
Tuesday, March 1, 2022
Giant, Florida circuit courts, Bird, Torpedo, Circuit, GEICO, Goliath, Circuit court, Atmosphere, Westchester Interfaith/Interagency Network for Disaster and Emergency Recovery, Celler, Eleventh, ERI, Public relations, Insurance

MIAMI-DADE COUNTY,Fla., March 1, 2022 /PRNewswire/ --Bobbie Celler and his company Emergency Recovery, Inc. ("ERI") sued GEICO after it issued a press release stating that Celler and ERI engaged in fraudulent conduct.

Key Points: 
  • MIAMI-DADE COUNTY,Fla., March 1, 2022 /PRNewswire/ --Bobbie Celler and his company Emergency Recovery, Inc. ("ERI") sued GEICO after it issued a press release stating that Celler and ERI engaged in fraudulent conduct.
  • GEICO's press release was issued after it filed a lawsuit against Celler and ERI alleging they were engaged in a deceptive scheme against GEICO.
  • The lawsuit was dismissed twice by a judge as having no legal basis against Celler and ERI.
  • CELLER filed his case- Emergency Recovery, Inc. and Bobbie Celler v. Government Employees Insurance company, Geico Indemnity Company, Geico Casualty Company, and Geico General Insurance Company.

Excellos Launches to Accelerate Innovation in the Cell and Gene Therapy Industry

Retrieved on: 
Tuesday, January 25, 2022
Health, Genetics, Other Science, Research, Science, Pharmaceutical, Biotechnology, Celler, Drug development, Acquisition, Therapy, THP, Industry, CA, Patient, VP, Life, TILS, Head, Collection, Research, CGMP, Business development, CEO, Science, Tissue, CSO, Mobile phone, Fine chemical, Excellos, Telegraph Hill Partners, EXCELLOS, TELEGRAPH HILL PARTNERS

Excellos will create highly characterized, standardized cell products and custom services that are essential for advanced therapeutics, said David Wellis Ph.D., CEO of Excellos.

Key Points: 
  • Excellos will create highly characterized, standardized cell products and custom services that are essential for advanced therapeutics, said David Wellis Ph.D., CEO of Excellos.
  • Chief Commercial Officer George Eastwood, brings significant experience in the cell and gene therapy space, with a focus on cGMP materials and cell manufacturing.
  • Most recently, as CSO of SDBB, he led the cell therapy, immunohematology, components manufacturing, and cord blood banking labs.
  • Excellos is dedicated to improving human life by providing critical products and services to life science research and the next generation of cell and gene therapies.